drugset / Trial / NCT00469183
Assessment of Atrophogenic Potential of Triple Combination Cream for Treatment of Melasma
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Evaluate atrophogenic potential of long-term use of Tri-Luma Cream on facial Melasma through biopsy examination.
Timeline
- Start
- 2006-05
- Primary completion
- 2007-04
- Completion
- 2007-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydroquinone | Small molecule | 4 % | Topical |
| Subject | Tretinoin | Small molecule | 0.05 % | Topical |
| Subject | fluocinolone acetonide | Small molecule | 0.1 % | Topical |